In a recent study, vvDD, expressing the fusion protein IL15Rα-IL15 and a fluorescent protein, was used to treat murine glioma GL261 in vitro and in vivo in combination with other treatments, including chemotherapy, peptide vaccine and adoptive T cell therapy (ACT). This evidence concerns the gene IL15RA and central nervous system cancer.